A multicenter prospective clinical study for the treatment of spleen and kidney insufficiency metrorrhagia and metrostaxis with Lingnan Hemostatic Prescription Erren Decoctio
- Conditions
- metrorrhagia and metrostaxis
- Registration Number
- ITMCTR1900002640
- Lead Sponsor
- The First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- Not specified
1. Between the ages of 13 and 55 years.
2. (1) suddenly a lot of violence under the vaginal bleeding; (2) blood dripping more than 14 days (in line with one of them).
3. (1) dark red or light red; (2) by thin (accord with one of them).
4. (1) weak waist and knees, chills and cold limbs, insomnia, tinnitus, and loss of libido; (2) loose stool, fatigue, poor diet, abnormal complexion (yellow or white) (at least in line with 1, 2 in each).
5. Tongue veins: the tongue is light and dark, with thin white coating and heavy and fine veins.
6. The subject voluntarily participates in the study and has signed the informed consent.
1. Vaginal bleeding caused by pregnancy.
2. Organic lesions, such as genital malignant tumor, uterine fibroids, adenomyosis and other abnormal uterine bleeding.
3. Abnormal uterine bleeding caused by reproductive tract infection.
4. Bleeding of vulva, vagina and cervix.
5. Abnormal uterine bleeding caused by cardiovascular diseases, liver diseases, blood system diseases, etc.
6. Hemoglobin less than 90g/L.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The bleeding time;
- Secondary Outcome Measures
Name Time Method Duration of hemostasis;Four coagulation;TCM symptom score;Blood analysis;